Skip to main content

Table 6 Data of liver function test and CBC in cirrhosis, HCC, control group

From: S100A14 protein as diagnostic and prognostic marker in hepatocellular carcinoma

 

Cirrhosis group

HCC group

Control group

One-way ANOVA

Mean ± SD

Min─max

Mean ± SD

Min─max

Mean ± SD

Min─max

F

p value

S.GPT (U/L)

55.91 ± 33.84

15–138

66.71 ± 43.17

22–201

15.35 ± 5.37

10–26

14.763

0.001

S.GOT (U/L)

84.71 ± 49.10

20–244

145.77 ± 161.89

30–821

18.85 ± 6.54

12–34

9.371

0.001

Albumin (g/dl)

2.40 ± 0.61

1.4–3.8

2.24 ± 0.55

1.3–3.6

4.34 ± 0.31

3.8–4.8

112.256

0.001

Bilirubin Total (mg/dl)

4.25 ± 3.89

0.46–20.7

5.92 ± 6.51

0.6–21.5

0.44 ± 0.17

0.2–0.8

8.561

0.001

Bilirubin Direct (mg/dl)

2.14 ± 2.09

0.1–10.7

3.35 ± 4.04

0.2–12.8

0.15 ± 0.05

0.1–0.2

8.080

0.001

Hemoglobin (g/dl)

10.23 ± 1.99

6–14.8

10.97 ± 1.42

8.3–14.6

12.14 ± 1.58

9.6–14.8

8.046

0.001

RBCs (× 106/μL)

3.59 ± 0.79

2.22–5.57

3.86 ± 0.58

3.2–5.79

4.45 ± 0.43

3.71–5.55

11.384

0.001

PLT (× 103/μL)

111.71 ± 71.43

24–342

114.31 ± 67.52

18–288

267.75 ± 52.54

174–356

42.545

0.001

WBC (× 103/μL)

7.99 ± 3.41

3–15

8.89 ± 5.14

2.5–18.3

6.62 ± 1.29

4.2–9

2.163

0.121

  1. This table shows that there was statistically significant increase in HCC in comparison to control and cirrhosis group with SGPT, SGOT, bilirubin total, and direct but there was statistically significant increase in control in comparison to HCC and cirrhosis group with albumin, HB, RBCs, and PLT